en · de · es · fr · pt
tb-500-notes.peptides4800.com › Wiki › Detection, Stability, And Regulatory Status — Evidence Review

Detection, Stability, And Regulatory Status — Evidence Review

By Editorial Desk · published 2025-11-08 · last reviewed 2025-11-28 · Wiki

If you have been reading about thymosin beta-4 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2025-11-28. Where a claim depends on a specific study, the study is described rather than over-claimed.

Detection, Stability, and Regulatory Status

Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.

Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.

Identity and Research Background

TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.

Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.

Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.

Tb-500 at a glance

PropertyValueNotes
Analytical methodLC-MS/MSPreferred confirmatory technique
AppearanceWhite to off-white powderLyophilised form
SolubilityFreely soluble in waterAlso described in saline
Storage temperatureBelow -20 °C for powderShort-term refrigeration for solutions
Regulatory statusProhibited in sportListed under peptide hormones

Identity And Naming Background

TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.

Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.

Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.

Related pages on this site

Handling, Storage, and Analysis

Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.

Reference notes

Before the war, education in the Gaza Strip was seen as a point of pride and a high priority. More than 95% of the children aged between 6-12 were attending school, with the majority graduating from high school. In December 2023, Jonathan Crick, a spokesperson for UNICEF in Jerusalem stated that there is absolutely no form of education or schooling in the Gaza Strip, and the about 625,000 school age children in the Strip are being deprived of an education due to war. In January 2024, the United Nations reported that children in Gaza would lose at least one year of education due to the war. According to the Palestinian Ministry of Education, the war has caused the death of about 4,327 students and injured about 7, 819 others by January 2024. Additionally at least 200 teachers have been killed and more than 500 injured by December 2023 with the number increasing to 231 teachers and administrators killed and 756 wounded by January 2024. Schools were closed at the start of the war, and underwent sustained bombing by the Israeli military, while others, such as the Israa University, were occupied and then destroyed by the Israeli military. By mid-December 2023 about 352 school buildings had been damaged, which is over 70% of the Strip's education infrastructure, with others being utilized to hold evacuated individuals and interiors utilized for fuel and survival. Some teachers attempted to continue lessons as they could, in courtyards and other areas not utilized by evacuated populations, with one teacher calling it an act of defiance and a small return to normal.

== External links == "Anatomy photo:21:st-1500". SUNY Downstate Medical Center. Archived from the original on March 5, 2016. – "Mediastinum: Pericardium (pericardial sac)" thoraxlesson4 at The Anatomy Lesson by Wesley Norman (Georgetown University) (heartpericardium) Atlas image: ht_pericard2 at the University of Michigan Health System – "MRI of chest, lateral view"

== Prognosis == With treatment, the majority of people with BPD can find relief from distressing symptoms and achieve remission, defined as a consistent relief from symptoms for at least two years. Remission rates are about 50–70% over five years. The remission rate is estimated to be around 50% at ten years, with 93% of people being able to achieve a two-year remission and 86% achieving at least a four-year remission, with a 30% risk of relapse over 10 years. Patient personality can play an important role during the therapeutic process, leading to better clinical outcomes. Recent research has shown that BPD patients undergoing dialectical behavior therapy (DBT) exhibit better clinical outcomes correlated with higher levels of the trait of agreeableness in the patient, compared to patients either low in agreeableness or not being treated with DBT. This association was mediated through the strength of a working alliance between patient and therapist; that is, more agreeable patients developed stronger working alliances with their therapists, which, in turn, led to better clinical outcomes. In addition to recovering from distressing symptoms, people with BPD can also achieve high levels of psychosocial functioning. A longitudinal study tracking the social and work abilities of participants with BPD found that six years after diagnosis, 56% of participants had good function in work and social environments, compared to 26% of participants when they were first diagnosed. Vocational achievement was generally more limited, even compared to those with other personality disorders.

Sources: en.wikipedia.org

Reference notes

=== Background === Until after the Second World War the landlocked British possession of Southern Rhodesia was not developed as an indigenous African territory, but rather as a unique state that reflected its multiracial character. This situation made it different from other lands that existed under colonial rule, as many Europeans had arrived to make permanent homes, populating the towns as traders or settling to farm the most productive soils. In 1922, faced with the decision to join the Union of South Africa as a fifth province or accept nearly full internal autonomy, the electorate cast its vote against South African integration. In view of the outcome of the referendum, the territory was annexed by the United Kingdom on 12 September 1923. Shortly after annexation, on 1 October 1923, the first constitution for the new Colony of Southern Rhodesia came into force. Under this constitution, Southern Rhodesia was given the right to elect its own thirty-member legislature, premier, and cabinet—although the British government retained a formal veto over measures affecting natives and dominated foreign policy. Over the course of the next three decades, Southern Rhodesia experienced a degree of economic expansion and industrialisation almost unrivalled in sub-Saharan Africa. Its natural abundance of mineral wealth—including large deposits of chromium and manganese—contributed to the high rate of conventional economic growth.

Selectivity: The reaction must be selective between endogenous functional groups to avoid side reactions with biological compounds Biological inertness: Reactive partners and resulting linkage should not possess any mode of reactivity capable of disrupting the native chemical functionality of the organism under study. Chemical inertness: The covalent link should be strong and inert to biological reactions. Kinetics: The reaction must be rapid so that covalent ligation is achieved prior to probe metabolism and clearance. The reaction must be fast, on the time scale of cellular processes (minutes) to prevent competition in reactions which may diminish the small signals of less abundant species. Rapid reactions also offer a fast response, necessary in order to accurately track dynamic processes. Reaction biocompatibility: Reactions have to be non-toxic and must function in biological conditions taking into account pH, aqueous environments, and temperature. Pharmacokinetics are a growing concern as bioorthogonal chemistry expands to live animal models. Accessible engineering: The chemical reporter must be capable of incorporation into biomolecules via some form of metabolic or protein engineering. Optimally, one of the functional groups is also very small so that it does not disturb native behavior.

=== Plasma or whole blood === In this article, all values (except the ones listed below) denote blood plasma concentration, which is approximately 60–100% larger than the actual blood concentration if the amount inside red blood cells (RBCs) is negligible. The precise factor depends on hematocrit as well as amount inside RBCs. Exceptions are mainly those values that denote total blood concentration, and in this article they are:

Sources: en.wikipedia.org

Reference notes

Co2+ + ⁠3/2⁠ S2O2−4 + 6 OH− + 4 CO → Co(CO)−4 + 3 SO2−3 + 3 H2O Some metal carbonyls are prepared using CO directly as the reducing agent. In this way, Hieber and Fuchs first prepared dirhenium decacarbonyl from the oxide:

== Pharmacodynamics == Etoxadrol is a non-competitive NMDA receptor antagonist. It binds with high affinity to the PCP binding site on the NMDA receptor (Ki = 107 nM, determined by the displacement of radiolabeled TCP). Normally, the inactivated NMDA receptor possesses a magnesium (Mg2+) block in the channel, blocking the passage of cations.

The formation of thermodynamically stable copernicium(II) and (IV) fluorides would be analogous to the chemistry of xenon. Analogous to mercury(II) cyanide (Hg(CN)2), copernicium is expected to form a stable cyanide, Cn(CN)2.

In November 1942, the Japanese built an airfield on Engebi Island. As they used it only for refueling planes between Truk and islands to the east, no aviation personnel were stationed there, and the island had only token defenses. When the Gilberts fell to the United States, the Imperial Japanese Army assigned defense of the atoll to the 1st Amphibious Brigade, formed from the 3rd Independent Garrison, which had previously been stationed in Manchukuo. The 1st Amphibious Brigade arrived on January 4, 1944. Some 2,586 of its 3,940 men were left to defend Eniwetok Atoll, supplemented by aviation personnel, civilian employees, and laborers. However, they were unable to finish the fortifications before the American attack came in February. During the ensuing Battle of Eniwetok, the Americans captured Enewetak in a five-day amphibious operation. Fighting mainly took place on Engebi Islet, site of the most important Japanese installation, although some combat occurred on the main islet of Enewetak itself and on Parry Island, where there was a Japanese seaplane base. Following its capture, the anchorage at Enewetok became a major US Naval Advance Base with Service Squadron 4 and Service Squadron 10 stationed in the lagoon. The daily average of ships present during the first half of July 1944 was 488; during the second half of July, the daily average number of ships at Enewetak was 283. Naval Base Eniwetok was part of the vast Naval Base Marshall Islands. US Navy Seabees of the 110th Naval Construction Battalion arrived on February 21 and 27 to begin construction of Stickell Field.

Sources: en.wikipedia.org

Frequently asked questions

How is the peptide detected in samples?

The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.

How should the powder be stored?

Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.

Is it approved for medical use?

It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.

Is TB-500 the same as thymosin beta-4?

No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.

Network